Abstract
The use of hormone replacement therapy (HRT) is a controversial decision for many women, yet few studies have evaluated the socio-demographic, psychological, and behavioral correlates of HRT use. This cross-sectional, mailed survey evaluated the associations of socioeconomic status, preventive health behaviors, knowledge and perceptions about HRT-related risks and benefits with HRT use among 428 women 50–70 years old in Vermont. The overall prevalence of HRT use was 40%. Women of moderate to high income were three times more likely than those of low income to use HRT. HRT use was significantly higher among women whose physician had encouraged use (58%) than among those who received ambivalent recommendations from their physicians (20%). Hysterectomy, higher income, younger age, regular adherence to cervical cancer screening, and recommendation by a provider were significantly associated with HRT use in multivariate analyses. There were no differences in HRT use according to level of concern about heart disease, osteoporosis, or breast cancer. A recommendation by a health care provider is a powerful predictor of HRT use, but disparities in use exist by socioeconomic status. Future research should examine why lower income women are less likely to use HRT and whether the discrepancy is due to inconsistent recommendations by health care providers.
Similar content being viewed by others
REFERENCES
Cauley JA, Seeley DG, Ensrud KE, Ettinger B, Black DM, Cummings SR Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-1593.
Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevent bone loss and fractures. Ann Intern Med 1985; 102:319-324.
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117:1016-1037.
Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335;453-461.
Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-762.
U.S. Preventive Services Task Force. Postmenopausal Hormone Prophylaxis. Guide to clinical preventive services, 2nd ed. Williams and Wilkins, Inc., 1996.
Nawaz H, Katz DL. American College of Preventive Medicine Practice Policy Statement. Perimenopausal and postmenopausal hormone replacement therapy. Am J Prev Med 1999; 17:250-254.
Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145:536-45.
Feinstein JS. The relationship between socioeconomic status and health: A review of the literature. Milb Quart 1993; 71:279-322.
Leveille SG, LaCroix AZ, Newton KM, Keenan NL. Older women and hormone replacement therapy: Factors influencing late life initiation. J Am Geriatr Soc 1997; 45:1496-1500.
Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999; 130:545-53.
Solberg LI, Brekke ML, Kottke TE. Are physicians less likely to recommend preventive services to low-SES patients? Preventive Medicine 1997; 26:350-357.
Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen therapy in elderly women. Am J Obstet Gynecol 1990; 163:1438-44.
Calle EE, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and pap smear screening in US women. Am J Public Health 1993; 83:53-60.
Rimer BK. Mammography use in the U.S.: trends and the impact of interventions. Ann Behav Med 1994; 16:317-326.
Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, re users healthier than nonusers? Am J Epidemiol 1996; 143:971-978.
Barrett-Conner E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115:455-6.
The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273:199-208.
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280:605-13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finley, C., Gregg, E.W., Solomon, L.J. et al. Disparities in Hormone Replacement Therapy Use by Socioeconomic Status in a Primary Care Population. Journal of Community Health 26, 39–50 (2001). https://doi.org/10.1023/A:1026537114638
Issue Date:
DOI: https://doi.org/10.1023/A:1026537114638